Case File
efta-efta01819434DOJ Data Set 10CorrespondenceEFTA Document EFTA01819434
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01819434
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jes Stale
From:
Jeffrey E
Sent
Mon 10/19/2009 11:53:43 AM
china is too important for such glib westernized answers.
Lighte: But our agenda differ profoundly. We arc not entering the retail Space outside of the U.S.
for now.
TAB: Right, so I'm wondering for J.P. Morgan, which is not doing retail, so therefore there is no
correlation?
Lighte: Retail is a completely different animal; thus, our different experience with the regulators
who have been both welcoming, reasonable and helpful to us.
TAB: What's your view on the business landscape in China, especially for US banks in light of the
events of the last couple of months.
Lighte: I think there's been a flight to quality, for example. It's been easier to market to clients
because of the difficulties other banks are having; but, I've also learned that business of bankers is
cycles, but no banker ever believes he's in one. But, I have enough experience to know that
arrogance can turn right around and bite us right in the neck.
So, I am loathe to be haughty these days because it can happen to anybody, I really mean that.
That being said, I am quietly proud of how J.P. Morgan is going about our business.
We are fortunate in enjoying some good publicity, these days; and I cannot help but feel that it's
much better for other people to say good things about us than for us to say it about ourselves.
I remember when I was a kid, an aunt of mine used to talk about her daughter all the time; and I
once asked my mother, "why don't you talk alot about me?" She replied with a smile, "I prefer to
let other people do that." It's exactly the same thing.
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jecvacationOsmail.com, and
destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00192054
EFTA01819434
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jecvacationosmail.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.